191 related articles for article (PubMed ID: 3573797)
1. Optimal myocardial preservation with an acalcemic crystalloid cardioplegic solution.
Boggs BR; Torchiana DF; Geffin GA; Titus JS; Redonnett BE; O'Keefe DD; Newell JB; Daggett WM
J Thorac Cardiovasc Surg; 1987 Jun; 93(6):838-46. PubMed ID: 3573797
[TBL] [Abstract][Full Text] [Related]
2. The effects of calcium and magnesium in hyperkalemic cardioplegic solutions on myocardial preservation.
Geffin GA; Love TR; Hendren WG; Torchiana DF; Titus JS; Redonnett BE; O'Keefe DD; Daggett WM
J Thorac Cardiovasc Surg; 1989 Aug; 98(2):239-50. PubMed ID: 2818723
[TBL] [Abstract][Full Text] [Related]
3. Oxygenation of cardioplegic solutions. Potential for the calcium paradox.
Hendren WG; Geffin GA; Love TR; Titus JS; Redonnett BE; O'Keefe DD; Daggett WM
J Thorac Cardiovasc Surg; 1987 Oct; 94(4):614-25. PubMed ID: 3116349
[TBL] [Abstract][Full Text] [Related]
4. Calcium-induced ventricular contraction during cardioplegic arrest.
Torchiana DF; Love TR; Hendren WG; Geffin GA; Titus JS; Redonnett BE; O'Keefe DD; Daggett WM
J Thorac Cardiovasc Surg; 1987 Oct; 94(4):606-13. PubMed ID: 3657262
[TBL] [Abstract][Full Text] [Related]
5. Benefits of glucose and oxygen in multidose cold cardioplegia.
Doherty NE; Turocy JF; Geffin GA; O'Keefe DD; Titus JS; Daggett WM
J Thorac Cardiovasc Surg; 1992 Feb; 103(2):219-29. PubMed ID: 1735987
[TBL] [Abstract][Full Text] [Related]
6. L-aspartate improves the functional recovery of explanted hearts stored in St. Thomas' Hospital cardioplegic solution at 4 degrees C.
Choong YS; Gavin JB
J Thorac Cardiovasc Surg; 1990 Mar; 99(3):510-7. PubMed ID: 2308369
[TBL] [Abstract][Full Text] [Related]
7. Oxygen requirements of the isolated rat heart during hypothermic cardioplegia. Effect of oxygenation on metabolic and functional recovery after five hours of arrest.
de Wit L; Coetzee A; Kotze J; Lochner A
J Thorac Cardiovasc Surg; 1988 Feb; 95(2):310-20. PubMed ID: 3339898
[TBL] [Abstract][Full Text] [Related]
8. Enhanced myocardial protection during ischemic arrest. Oxygenation of a crystalloid cardioplegic solution.
Bodenhamer RM; DeBoer LW; Geffin GA; O'Keefe DD; Fallon JT; Aretz TH; Haas GS; Daggett WM
J Thorac Cardiovasc Surg; 1983 May; 85(5):769-80. PubMed ID: 6843158
[TBL] [Abstract][Full Text] [Related]
9. The effect of temperature and hematocrit level of oxygenated cardioplegic solutions on myocardial preservation.
Rousou JA; Engelman RM; Breyer RH; Otani H; Lemeshow S; Das DK
J Thorac Cardiovasc Surg; 1988 Apr; 95(4):625-30. PubMed ID: 3352296
[TBL] [Abstract][Full Text] [Related]
10. Maintenance of the myocardial thiol pool by N-acetylcysteine. An effective means of improving cardioplegic protection.
Menasché P; Grousset C; Gauduel Y; Mouas C; Piwnica A
J Thorac Cardiovasc Surg; 1992 May; 103(5):936-44. PubMed ID: 1569775
[TBL] [Abstract][Full Text] [Related]
11. Influence of the pH of cardioplegic solutions on intracellular pH, high-energy phosphates, and postarrest performance. Protective effects of acidotic, glutamate-containing cardioplegic perfusates.
Bernard M; Menasche P; Canioni P; Fontanarava E; Grousset C; Piwnica A; Cozzone P
J Thorac Cardiovasc Surg; 1985 Aug; 90(2):235-42. PubMed ID: 2410746
[TBL] [Abstract][Full Text] [Related]
12. Cardioplegic protection of hearts with pre-arrest ischaemic injury: effect of glucose, aspartate, and lactobionate.
Choong YS; Gavin JB; Cottier DS
Thorac Cardiovasc Surg; 1995 Dec; 43(6):331-7. PubMed ID: 8775858
[TBL] [Abstract][Full Text] [Related]
13. The effect of amino acids on the ischemic heart. Improvement of oxygenated crystalloid cardioplegic solution by an enriched branched chain amino acid formulation.
Schwalb H; Izhar U; Yaroslavsky E; Borman JB; Uretzky G
J Thorac Cardiovasc Surg; 1989 Oct; 98(4):551-6. PubMed ID: 2796362
[TBL] [Abstract][Full Text] [Related]
14. [Functional and metabolic effects of nicardipine on ischemic rat hearts with multidose potassium cardioplegia].
Tachibana H
Nihon Kyobu Geka Gakkai Zasshi; 1990 Apr; 38(4):630-40. PubMed ID: 2373897
[TBL] [Abstract][Full Text] [Related]
15. Improved myocardial protection by oxygenation of St. Thomas' Hospital cardioplegic solutions. Studies in the rat.
Ledingham SJ; Braimbridge MV; Hearse DJ
J Thorac Cardiovasc Surg; 1988 Jan; 95(1):103-11. PubMed ID: 3336223
[TBL] [Abstract][Full Text] [Related]
16. New solution for prolonged myocardial preservation for transplantation.
Schwalb H; Grinberg L; Yaroslavsky-Houminer E; Lazarovici G; Von Oppell U; Worthington M; Merin G; Borman JB
J Heart Lung Transplant; 1998 Feb; 17(2):222-9. PubMed ID: 9513861
[TBL] [Abstract][Full Text] [Related]
17. Normocalcemic blood or crystalloid cardioplegia provides better neonatal myocardial protection than does low-calcium cardioplegia.
Pearl JM; Laks H; Drinkwater DC; Meneshian A; Sun B; Gates RN; Chang P
J Thorac Cardiovasc Surg; 1993 Feb; 105(2):201-6. PubMed ID: 8429645
[TBL] [Abstract][Full Text] [Related]
18. Effects of potassium cardioplegia on high-energy phosphate kinetics during circulatory arrest with deep hypothermia in the newborn piglet heart.
Clark BJ; Woodford EJ; Malec EJ; Norwood CR; Pigott JD; Norwood WI
J Thorac Cardiovasc Surg; 1991 Feb; 101(2):342-9. PubMed ID: 1992245
[TBL] [Abstract][Full Text] [Related]
19. The effect of L-arginine on myocardial recovery after cardioplegic arrest and ischemia under moderate and deep hypothermia.
Amrani M; Gray CC; Smolenski RT; Goodwin AT; London A; Yacoub MH
Circulation; 1997 Nov; 96(9 Suppl):II-274-9. PubMed ID: 9386110
[TBL] [Abstract][Full Text] [Related]
20. Toward a new cold and warm nondepolarizing, normokalemic arrest paradigm for orthotopic heart transplantation.
Rudd DM; Dobson GP
J Thorac Cardiovasc Surg; 2009 Jan; 137(1):198-207. PubMed ID: 19154926
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
